"Neurovations, a patient care and innovation company, was founded in 1992 by CEO Dr. Eric Grigsby. Today, Neurovations is a national leader in medical device and pharmaceutical innovation, clinical research, and a world-class education program focusing in pain and neuroscience. Dr. Grigsby is deeply connected to the healthcare community through our non-profit HealthRoots Foundation and to the Napa community through Rocca Family Vineyards, a producer of award-winning wines. Our unwavering mission is to inspire hope and to contribute to the health and well-being of our patients and communities through integrated clinical practice, research, and education."

During the past decade, Neurovations (Napa Pain Institute) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Neurovations (Napa Pain Institute)" are "Osteoarthritis, Knee" (2 trials). Many other conditions were trialed in "Neurovations (Napa Pain Institute)" in a lesser frequency.

Most popular intervention types in "Neurovations (Napa Pain Institute)" are "Biological" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "XT-150" (2 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Neurovations (Napa Pain Institute)" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Neurovations (Napa Pain Institute)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Neurovations (Napa Pain Institute), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Neurovations (Napa Pain Institute), 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".